Stock Analiz

Surgery Partners, Inc. (SGRY) financials: revenue, earnings and cash flow

Fiscal 2015–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Surgery Partners’s revenue went from $960M in fiscal 2015 to $3.3B in fiscal 2025, growth of about 13.2% a year.

Net income in fiscal 2025 was -$78M, a net margin of -2.4%; the best year in this period was 2016 with $9M.

Over the twelve months to September 30, 2026, revenue was $3.4B and net income -$87M.

Free cash flow was $196M in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count rose 240% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2015: $960M152016: $1.1B162018: $1.8B182019: $1.8B192020: $1.9B202021: $2.2B212022: $2.5B222023: $2.7B232024: $3.1B242025: $3.3B25$3.3B
Net income
2015: $1M152016: $9M162018: -$206M182019: -$75M192020: -$116M202021: -$71M212022: -$55M222023: -$12M232024: -$168M242025: -$78M25-$78M
Free cash flow
2015: $51M152016: $86M162018: $105M182019: $56M192020: $204M202021: $30M212022: $78M222023: $205M232024: $210M242025: $196M25$196M
EPS (diluted)
2015: $0.04152016: $0.20162018: $-4.96182019: $-2.29192020: $-3.19202021: $-1.12212022: $-0.59222023: $-0.09232024: $-1.33242025: $-0.6125$-0.61

Income statement

Fiscal yearTTM2025202420232022202120202019201820162015
Revenue$3.4B$3.3B$3.1B$2.7B$2.5B$2.2B$1.9B$1.8B$1.8B$1.1B$960M
Gross profit———————$424M$410M$324M$291M
Operating income$364M$390M$349M$328M$345M$302M$183M$236M$78M$196M$145M
Net income-$87M-$78M-$168M-$12M-$55M-$71M-$116M-$75M-$206M$9M$1M
EPS (diluted)$-0.67$-0.61$-1.33$-0.09$-0.59$-1.12$-3.19$-2.29$-4.96$0.20$0.04
R&D———————————
Revenue growth—+6.2%+13.5%+8.0%+14.1%+19.6%+1.6%+3.4%+54.7%+19.3%+138.0%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820162015
Operating cash flow$278M$274M$300M$294M$159M$87M$247M$130M$145M$125M$84M
Capital spending-$75M-$79M-$90M-$89M-$81M-$58M-$43M-$74M-$40M-$39M-$33M
Free cash flow$203M$196M$210M$205M$78M$30M$204M$56M$105M$86M$51M
Dividends paid—$0$0$0$0$0$0$0$0$0$0
Buybacks——————$0$0$2M$0$0
Stock-based pay$13M$15M$33M$18M$18M$17M$13M$10M$9M$2M$8M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820162015
Cash—$240M$270M$196M$283M$390M$318M$93M$184M$70M$58M
Debt—$4.0B$3.7B$3.1B$2.9B$3.3B$3.2B$2.9B$2.3B$1.4B$1.3B
Equity—$1.7B$1.8B$2.0B$2.0B$1.1B$116M$297M$405M$10M-$4M
Total assets—$8.1B$7.9B$6.9B$6.7B$6.1B$5.4B$5.0B$4.7B$2.3B$2.1B
Shares (diluted)129M127M126M126M92M72M49M48M48M48M37M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820162015
Gross margin———————23.1%23.2%28.3%30.3%
Operating margin10.8%11.8%11.2%12.0%13.6%13.6%9.8%12.9%4.4%17.2%15.1%
Net margin-2.6%-2.4%-5.4%-0.4%-2.1%-3.2%-6.2%-4.1%-11.6%0.8%0.1%
FCF margin6.0%5.9%6.7%7.5%3.1%1.3%11.0%3.0%5.9%7.5%5.3%
ROIC—5.4%5.0%5.1%5.5%5.5%4.4%5.8%2.2%10.7%9.1%
ROE—-4.5%-9.4%-0.6%-2.7%-6.5%-100.4%-25.2%-50.8%97.7%-35.5%

Frequently asked questions

What is Surgery Partners’s annual revenue?

$3.3B in fiscal 2025 and $3.4B over the twelve months to September 30, 2026.

How much profit does Surgery Partners make?

Net income was -$78M in fiscal 2025 (net margin -2.4%).

Is Surgery Partners’s revenue growing?

Yes: revenue rose 6.2% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.